id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276092-4e4muqnu	Dal-Re, Rafael	Waste in COVID-19 clinical trials conducted in western Europe	2020-07-07		.txt	text/plain	1277	69	54	A cross-sectional analysis was carried out based on a series of searches conducted on May 20-21, 2020 looking for non-industry-sponsored, ongoing trials, aiming to assess medicines or convalescent plasma for the treatment of COVID-19 patients, in the 5 largest European countries and 2 regions (Benelux, Scandinavia). The following information was extracted from each trial: single-arm or randomized controlled trial (RCT), blinding, and planned sample size; whether the trial was multicenter, had a control (standard of care) arm and a Data Monitoring Committee. Limited useful information should be expected from single-arm trials, RCTs recruiting ≤50 participants/arm and those with no standard of care arm. However, it should be highlighted that it is rather surprising why some trials carried out in all the countries/regions included in this study seemed not to be registered on the EudraCT database (from which the EU-CTR obtains all the information), something that should be expected from all trials conducted with medicines in Europe.	./cache/cord-276092-4e4muqnu.txt	./txt/cord-276092-4e4muqnu.txt